Studies have shown that active fund managers routinely underperform the S&P500 index*​

Tvardi Therapeutics, Inc. (NASDAQ: TVRD)

TVRD Stock Predictions and Ratings

WSX Rating:
NOT AVAILABLE
WSX Forecast (1yr):
NOT AVAILABLE
Analyst Rating:
HOLD
Analyst Forecast (1yr):
361.90%

TVRD Stock Analysis

TVRD PE Ratio:

TVRD PEG Ratio: Not Available

TVRD Forward EPS Growth (12 month): 0.00%

TVRD PS Ratio:

TVRD PSG Ratio: Not Available

TVRD Forward Revenue Growth (12 month): 0.00%

TVRD Articles

No data was found